{"entity":{"type":"insider","cik":"0001400241","url":"/insider/0001400241","json_url":"/insider/0001400241.json","name":"NewcoGen Group, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":56,"n_filings":13,"first":"2007-05-31","last":"2015-07-29","span_basis":"filed_date"},"name_variants":[{"name":"NewcoGen Group, Inc.","source":"filing","n_filings":13,"first_seen":"2007-05-31","last_seen":"2015-07-29"}],"transactions":[{"id":8863656,"accession":"0001181431-15-008835","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-15-008835","line_url":"/filing/0001181431-15-008835","is_derivative":false,"issuer_cik":"0001131095","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001131095","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; AFEYAN NOUBAR; AGTC ADVISORS FUND LP; Flagship Ventures Management, Inc.; AGTC Partners, L.P.","owner_display_name":"NewcoGen Group, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302.0,"shares_display":"302","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":685.54,"total_display":"685.54","total_whole":"686","shares_owned_after":56804.0,"shares_owned_after_display":"56,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-27","filed_date":"2015-07-29","scope":"insider","n_lines":6},{"id":8236568,"accession":"0001181431-15-008833","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-15-008833","line_url":"/filing/0001181431-15-008833","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Management, Inc.; NewcoGen Group, Inc.; AGTC Partners, L.P.; AFEYAN NOUBAR; Applied Genomic Technology Capital Fund LP","owner_display_name":"Flagship Ventures Management, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4980.0,"shares_display":"4,980","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":11304.6,"total_display":"11,304.60","total_whole":"11,305","shares_owned_after":763330.0,"shares_owned_after_display":"763,330","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-27","filed_date":"2015-07-29","scope":"insider","n_lines":6},{"id":7067261,"accession":"0001181431-14-038231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-038231","line_url":"/filing/0001181431-14-038231","is_derivative":false,"issuer_cik":"0001097548","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097548","owner_cik":null,"owner_name":"Flagship Ventures Management, Inc.; AFEYAN NOUBAR; KANIA EDWIN M JR; NewcoGen Group, Inc.; NEWCOGEN GROUP LLC","owner_display_name":"Flagship Ventures Management, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1848.0,"shares_display":"1,848","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":850.08,"total_display":"850.08","total_whole":"850","shares_owned_after":2484192.0,"shares_owned_after_display":"2,484,192","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-05","scope":"insider","n_lines":3},{"id":6965980,"accession":"0001181431-14-038230","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-038230","line_url":"/filing/0001181431-14-038230","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures Management, Inc.; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2463.0,"shares_display":"2,463","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":1132.98,"total_display":"1,132.98","total_whole":"1,133","shares_owned_after":662654.0,"shares_owned_after_display":"662,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-05","scope":"insider","n_lines":5},{"id":6520613,"accession":"0001181431-14-038228","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-038228","line_url":"/filing/0001181431-14-038228","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"ST NewcoGen LLC; AFEYAN NOUBAR; KANIA EDWIN M JR; NewcoGen Group, Inc.; Flagship Ventures Management, Inc.","owner_display_name":"ST NewcoGen LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":257.0,"shares_display":"257","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":118.22,"total_display":"118.22","total_whole":"118","shares_owned_after":98352.0,"shares_owned_after_display":"98,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-05","scope":"insider","n_lines":5},{"id":6185372,"accession":"0001181431-14-038229","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-038229","line_url":"/filing/0001181431-14-038229","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Long Reign Holding LLC; AFEYAN NOUBAR; Flagship Ventures Management, Inc.; NewcoGen Group, Inc.; KANIA EDWIN M JR","owner_display_name":"NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":119.6,"total_display":"119.60","total_whole":"120","shares_owned_after":98570.0,"shares_owned_after_display":"98,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-05","scope":"insider","n_lines":5},{"id":4680890,"accession":"0001181431-13-006146","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-006146","line_url":"/filing/0001181431-13-006146","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"KANIA EDWIN M JR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; AGTC Partners, L.P.; AGTC ADVISORS FUND LP; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN GROUP LLC; Applied Genomic Technology Capital Fund LP","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":1764286.0,"shares_owned_after_display":"1,764,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-01-30","filed_date":"2013-02-01","scope":"insider","n_lines":5},{"id":3059637,"accession":"0001181431-12-046973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-046973","line_url":"/filing/0001181431-12-046973","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Group, Inc.; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; NewcoGen Elan LLC; AFEYAN NOUBAR","owner_display_name":"NewcoGen Group, Inc.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":478.06,"total_display":"478.06","total_whole":"478","shares_owned_after":298137.0,"shares_owned_after_display":"298,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-20","filed_date":"2012-08-22","scope":"insider","n_lines":4},{"id":2891911,"accession":"0001181431-12-032084","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-12-032084","line_url":"/filing/0001181431-12-032084","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; NewcoGen Group, Inc.; Flagship Ventures Management, Inc.; NewcoGen PE LLC; AFEYAN NOUBAR","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141.0,"shares_display":"141","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":556.95,"total_display":"556.95","total_whole":"557","shares_owned_after":130867.0,"shares_owned_after_display":"130,867","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-21","filed_date":"2012-05-23","scope":"insider","n_lines":5},{"id":9160361,"accession":"0001181431-11-009580","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-26","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714286.0,"shares_display":"714,286","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":5000002.0,"total_display":"5,000,002.00","total_whole":"5,000,002","shares_owned_after":714286.0,"shares_owned_after_display":"714,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160360,"accession":"0001181431-11-009580","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-25","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":271429.0,"shares_display":"271,429","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1900003.0,"total_display":"1,900,003.00","total_whole":"1,900,003","shares_owned_after":2351447.0,"shares_owned_after_display":"2,351,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160359,"accession":"0001181431-11-009580","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-24","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42858.0,"shares_display":"42,858","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":300006.0,"total_display":"300,006.00","total_whole":"300,006","shares_owned_after":2184800.0,"shares_owned_after_display":"2,184,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160358,"accession":"0001181431-11-009580","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-23","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35715.0,"shares_display":"35,715","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":250005.0,"total_display":"250,005.00","total_whole":"250,005","shares_owned_after":526560.0,"shares_owned_after_display":"526,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160357,"accession":"0001181431-11-009580","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-22","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21428.0,"shares_display":"21,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":149996.0,"total_display":"149,996.00","total_whole":"149,996","shares_owned_after":92294.0,"shares_owned_after_display":"92,294","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"},{"id":9160356,"accession":"0001181431-11-009580","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580#line-21","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21428.0,"shares_display":"21,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":149996.0,"total_display":"149,996.00","total_whole":"149,996","shares_owned_after":92126.0,"shares_owned_after_display":"92,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider"}],"collapsed":true,"next_cursor":"2011-02-09|9160356","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001407038","name":"BG Medicine, Inc.","url":"/issuer/0001407038","role":"Ten percent owner","n_filings":10,"first_seen":"2011-02-11","last_seen":"2015-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2007-05-31","last_seen":"2009-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001400241","retrieved_at":"2026-08-22T12:39:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}